Alzheimer's: focus on carer support and drugs to contain costs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.286, 2000-01, pp. : 4-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

LifeMasters' DM programme helps contain claim costs in CHF patients

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 300, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Pay for performance an ethical way to contain drug costs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 570, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Alzheimer's disease: costs after 10 years

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 273, 2000-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

UK Department of Health Guidance on Prescribing for Impotence Following the Introduction of Sildenafil: Potential to Contain Costs in the Average Health Authority District

By Ashton-Key M.

PharmacoEconomics, Vol. 20, Iss. 12, 2002-01 ,pp. : 839-846

Adis International

Access to resources Recommend Favorite

Do reference-based pricing policies really contain drug costs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 320, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite